Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Winkelmann

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Nature Reviews. Neurology|April 7, 2022
Vaccination and immunotherapies in neuroimmunological diseasesAlexander Winkelmann, Micha Loebermann, Michael Barnett, et al.
Nature Reviews. Neurology|March 5, 2016
Disease-modifying therapies and infectious risks in multiple sclerosisAlexander Winkelmann, Micha Loebermann, Emil C Reisinger, et al.
Annals of Neurology|October 27, 2011
Fingolimod treatment for multiple sclerosis patients What do we do with varicella?Alexander Winkelmann, Micha Loebermann, Emil C Reisinger, et al.
Clinical Neurology and Neurosurgery|July 12, 2014
Progressive multifocal leukoencephalopathy in a patient with pre-clinical primary biliary cirrhosisStefanie Meister, Reiner Benecke, Fatima B König, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 11, 2020
Tick-borne encephalitis vaccination in multiple sclerosis: A prospective, multicenter studyAlexander Winkelmann, Christoph Metze, Silvius Frimmel, et al.
Nature Reviews. Neurology|January 25, 2012
Vaccination against infection in patients with multiple sclerosisMicha Loebermann, Alexander Winkelmann, Hans-Peter Hartung, et al.
CNS Neuroscience & Therapeutics|July 26, 2018
Immunogenicity and predictors of response to a single dose trivalent seasonal influenza vaccine in multiple sclerosis patients receiving disease-modifying therapiesChristoph Metze, Alexander Winkelmann, Micha Loebermann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 24, 2011
Severe relapse of multiple sclerosis during plasma exchange treatmentBurkhard Matzke, Christoph Metze, Alexander Winkelmann, et al.
Frontiers in Immunology|August 24, 2019
Vaccination in Multiple Sclerosis: Friend or Foe?Tobias Zrzavy, Herwig Kollaritsch, Paulus S Rommer, et al.
Der Nervenarzt|July 7, 2021
[The corona pandemic and multiple sclerosis: vaccinations and their implications for patients-Part 2: vaccine technologies]Tobias Monschein, Tobias Zrzavy, Micha Löbermann, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Nature Reviews. Neurology|April 7, 2022
Vaccination and immunotherapies in neuroimmunological diseasesAlexander Winkelmann, Micha Loebermann, Michael Barnett, et al.
Nature Reviews. Neurology|March 5, 2016
Disease-modifying therapies and infectious risks in multiple sclerosisAlexander Winkelmann, Micha Loebermann, Emil C Reisinger, et al.
Annals of Neurology|October 27, 2011
Fingolimod treatment for multiple sclerosis patients What do we do with varicella?Alexander Winkelmann, Micha Loebermann, Emil C Reisinger, et al.
Clinical Neurology and Neurosurgery|July 12, 2014
Progressive multifocal leukoencephalopathy in a patient with pre-clinical primary biliary cirrhosisStefanie Meister, Reiner Benecke, Fatima B König, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 11, 2020
Tick-borne encephalitis vaccination in multiple sclerosis: A prospective, multicenter studyAlexander Winkelmann, Christoph Metze, Silvius Frimmel, et al.
Nature Reviews. Neurology|January 25, 2012
Vaccination against infection in patients with multiple sclerosisMicha Loebermann, Alexander Winkelmann, Hans-Peter Hartung, et al.
CNS Neuroscience & Therapeutics|July 26, 2018
Immunogenicity and predictors of response to a single dose trivalent seasonal influenza vaccine in multiple sclerosis patients receiving disease-modifying therapiesChristoph Metze, Alexander Winkelmann, Micha Loebermann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 24, 2011
Severe relapse of multiple sclerosis during plasma exchange treatmentBurkhard Matzke, Christoph Metze, Alexander Winkelmann, et al.
Frontiers in Immunology|August 24, 2019
Vaccination in Multiple Sclerosis: Friend or Foe?Tobias Zrzavy, Herwig Kollaritsch, Paulus S Rommer, et al.
Der Nervenarzt|July 7, 2021
[The corona pandemic and multiple sclerosis: vaccinations and their implications for patients-Part 2: vaccine technologies]Tobias Monschein, Tobias Zrzavy, Micha Löbermann, et al.
Pageof 5